These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 23256109

  • 1. Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients.
    Soldano S, Montagna P, Brizzolara R, Ferrone C, Parodio A, Sulli A, Seriolo B, Villaggio B, Cutolo M.
    Reumatismo; 2012 Dec 11; 64(5):326-34. PubMed ID: 23256109
    [Abstract] [Full Text] [Related]

  • 2. Effects of macitentan and its active metabolite on cultured human systemic sclerosis and control skin fibroblasts.
    Cutolo M, Montagna P, Brizzolara R, Smith V, Alessandri E, Villaggio B, Sulli A, Tavilla PP, Pizzorni C, Soldano S.
    J Rheumatol; 2015 Mar 11; 42(3):456-63. PubMed ID: 25593238
    [Abstract] [Full Text] [Related]

  • 3. Effect of endothelin inhibition on lung fibroblasts on patients with systemic sclerosis.
    Corrado A, Neve A, Costantino E, Palladino GP, Foschino Barbaro MP, Cantatore FP.
    Minerva Med; 2013 Oct 11; 104(5):505-17. PubMed ID: 24101108
    [Abstract] [Full Text] [Related]

  • 4. Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts.
    Cutolo M, Ruaro B, Montagna P, Brizzolara R, Stratta E, Trombetta AC, Scabini S, Tavilla PP, Parodi A, Corallo C, Giordano N, Paolino S, Pizzorni C, Sulli A, Smith V, Soldano S.
    Arthritis Res Ther; 2018 May 02; 20(1):77. PubMed ID: 29720235
    [Abstract] [Full Text] [Related]

  • 5. Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1.
    Shi-Wen X, Denton CP, Dashwood MR, Holmes AM, Bou-Gharios G, Pearson JD, Black CM, Abraham DJ.
    J Invest Dermatol; 2001 Mar 02; 116(3):417-25. PubMed ID: 11231316
    [Abstract] [Full Text] [Related]

  • 6. Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts.
    Shi-Wen X, Renzoni EA, Kennedy L, Howat S, Chen Y, Pearson JD, Bou-Gharios G, Dashwood MR, du Bois RM, Black CM, Denton CP, Abraham DJ, Leask A.
    Matrix Biol; 2007 Oct 02; 26(8):625-32. PubMed ID: 17681742
    [Abstract] [Full Text] [Related]

  • 7. Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in mice.
    Akashi K, Saegusa J, Sendo S, Nishimura K, Okano T, Yagi K, Yanagisawa M, Emoto N, Morinobu A.
    Arthritis Res Ther; 2016 May 21; 18(1):113. PubMed ID: 27209208
    [Abstract] [Full Text] [Related]

  • 8. Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.
    Soldano S, Pizzorni C, Paolino S, Trombetta AC, Montagna P, Brizzolara R, Ruaro B, Sulli A, Cutolo M.
    PLoS One; 2016 May 21; 11(11):e0166433. PubMed ID: 27846260
    [Abstract] [Full Text] [Related]

  • 9. Role of endothelin-1 in the skin fibrosis of systemic sclerosis.
    Jing J, Dou TT, Yang JQ, Chen XB, Cao HL, Min M, Cai SQ, Zheng M, Man XY.
    Eur Cytokine Netw; 2015 May 21; 26(1):10-4. PubMed ID: 25990837
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation.
    Kissin EY, Lemaire R, Korn JH, Lafyatis R.
    Arthritis Rheum; 2002 Nov 21; 46(11):3000-9. PubMed ID: 12428243
    [Abstract] [Full Text] [Related]

  • 11. Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts.
    Cipriani P, Di Benedetto P, Ruscitti P, Verzella D, Fischietti M, Zazzeroni F, Liakouli V, Carubbi F, Berardicurti O, Alesse E, Giacomelli R.
    Arthritis Res Ther; 2015 Sep 10; 17(1):247. PubMed ID: 26357964
    [Abstract] [Full Text] [Related]

  • 12. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.
    Akamata K, Asano Y, Aozasa N, Noda S, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Sato S.
    Arthritis Res Ther; 2014 Apr 03; 16(2):R86. PubMed ID: 24708674
    [Abstract] [Full Text] [Related]

  • 13. Inflammatory responses after endothelin B (ETB) receptor activation in human monocytes: new evidence for beneficial anti-inflammatory potency of ETB-receptor antagonism.
    Juergens UR, Racké K, Uen S, Haag S, Lamyel F, Stöber M, Gillissen A, Novak N, Vetter H.
    Pulm Pharmacol Ther; 2008 Apr 03; 21(3):533-9. PubMed ID: 18295521
    [Abstract] [Full Text] [Related]

  • 14. Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen.
    Lemaire R, Farina G, Kissin E, Shipley JM, Bona C, Korn JH, Lafyatis R.
    Arthritis Rheum; 2004 Mar 03; 50(3):915-26. PubMed ID: 15022335
    [Abstract] [Full Text] [Related]

  • 15. Endothelin receptor antagonists as disease modifiers in systemic sclerosis.
    Shetty N, Derk CT.
    Inflamm Allergy Drug Targets; 2011 Feb 03; 10(1):19-26. PubMed ID: 21184655
    [Abstract] [Full Text] [Related]

  • 16. Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells.
    Soldano S, Paolino S, Pizzorni C, Trombetta AC, Montagna P, Brizzolara R, Corallo C, Giordano N, Sulli A, Cutolo M.
    Clin Exp Rheumatol; 2017 Feb 03; 35(3):484-493. PubMed ID: 28134077
    [Abstract] [Full Text] [Related]

  • 17. Endothelins: effect on matrix biosynthesis and proliferation in normal and scleroderma fibroblasts.
    Xu S, Denton CP, Holmes A, Dashwood MR, Abraham DJ, Black CM.
    J Cardiovasc Pharmacol; 1998 Feb 03; 31 Suppl 1():S360-3. PubMed ID: 9595482
    [Abstract] [Full Text] [Related]

  • 18. Endothelin and sex hormones modulate the fibronectin synthesis by cultured human skin scleroderma fibroblasts.
    Soldano S, Montagna P, Villaggio B, Parodi A, Gianotti G, Sulli A, Seriolo B, Secchi ME, Cutolo M.
    Ann Rheum Dis; 2009 Apr 03; 68(4):599-602. PubMed ID: 18952637
    [Abstract] [Full Text] [Related]

  • 19. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.
    Corallo C, Cutolo M, Kahaleh B, Pecetti G, Montella A, Chirico C, Soldano S, Nuti R, Giordano N.
    Arthritis Res Ther; 2016 Oct 06; 18(1):228. PubMed ID: 27716320
    [Abstract] [Full Text] [Related]

  • 20. Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma).
    Wallis DD, Tan FK, Kielty CM, Kimball MD, Arnett FC, Milewicz DM.
    Arthritis Rheum; 2001 Aug 06; 44(8):1855-64. PubMed ID: 11508439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.